Evidence map›Paper›PMID 34012652›Full record

ArticleJournal of gastrointestinal oncology2021

Outcomes of young patients diagnosed with locally advanced rectal cancer.

Rosemary Habib, Nicholas G Burgess, Michael J Bourke, Mark Wong, Nicholas Wilcken, James Toh, Toufic El-Khoury, Nimalan Pathma-Nathan, Grahame Ctercteko, Jayasingham Jayamohan and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Rosemary HabibWestmead Clinical School, The University of Sydney, Sydney, Australia.
Nicholas G BurgessWestmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Michael J BourkeWestmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Mark WongDepartment of Medical Oncology, Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia.
Nicholas WilckenDepartment of Medical Oncology, Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia.
James TohWestmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Toufic El-KhouryWestmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Nimalan Pathma-NathanDivision of Colorectal Surgery, Department of Surgery, Westmead Hospital, Sydney, New South Wales, Australia.
Grahame CterctekoDivision of Colorectal Surgery, Department of Surgery, Westmead Hospital, Sydney, New South Wales, Australia.
Jayasingham JayamohanWestmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Kenneth MicklethwaiteWestmead Clinical School, The University of Sydney, Sydney, Australia.
Adnan NagrialDepartment of Medical Oncology, Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, New South Wales, Australia.
Westmead Hospital · AUBlacktown & Mount Druitt Hospital · AUThe University of Sydney · AUThe University of Notre Dame Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of rectal cancer is higher in the older population. In developed nations, there has been a rise in incidence in young onset colorectal cancer (CRC). We examined the outcomes of locally advanced rectal cancer (LARC) in younger patients (yRC) compared with older patients, using a retrospective audit.

methodsAll cases of LARC referred to two tertiary referral cancer centres in Western Sydney were examined. Patient demographics, presenting symptoms, treatment, relapse free survival (RFS), overall survival (OS) and progression free survival (PFS) were obtained. Under 50 years old was used as the cut-off age for defining yRC.

resultsAll 145 consecutive patients were treated for LARC, including 28 in the yRC and 117 in the older patient group. Median follow-up was 54 months. yRC were more likely to complete neoadjuvant therapy (100%

conclusionsPatients under 50 years with LARC are more likely to have MSI tumours with a more aggressive disease course and poorer RFS, PFS and OS. Initiatives to improve early detection of these patients may improve outcomes. Further research is necessary to understand this disease and optimise its treatment.

Indexed as

cancercolorectal cancer (CRC)neoadjuvant treatmentrectal bleedingRectal cancer

Identifiers

PMID34012652
PMCPMC8107615
OpenAlexW3154610002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.